Metformin (Glumetza, Fortamet) is an oral medication that helps control blood sugar in people with type 2 diabetes and isn't a GLP-1 receptor agonist
While increased sweating is not listed as a common side effect of semaglutide in the SmPC, patients taking Ozempic alongside insulin or sulfonylureas should be aware that sweating can be a symptom of hypoglycaemia
However, because we have determined that the cost of reporting on these measures outweighs the benefits of retaining them in the program, it would place an undue burden on hospitals and ASCs to continue requiring reporting on these measures for an additional year
Understanding how to mix peptides with bacteriostatic water properly is essential for anyone using reconstituted formulations
An emphatic increase in the expression of two markers of mucin levels, MUC2 and MUC5 genes, was observed after metformin treatment (Kyriachenko et al., 2019)
Current Pharmaceutical Design, 24(18), 1947-1956